Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1491744974;44975;44976 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
N2AB1327640051;40052;40053 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
N2A1234937270;37271;37272 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
N2B585217779;17780;17781 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
Novex-1597718154;18155;18156 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
Novex-2604418355;18356;18357 chr2:178624531;178624530;178624529chr2:179489258;179489257;179489256
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Ig-100
  • Domain position: 65
  • Structural Position: 148
  • Q(SASA): 0.6651
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/G None None 0.822 N 0.483 0.243 0.20549828249 gnomAD-4.0.0 4.79232E-06 None None None None N None 0 0 None 0 0 None 0 0 6.29927E-06 0 0
E/K None None 0.822 N 0.467 0.293 0.191931220699 gnomAD-4.0.0 2.05386E-06 None None None None N None 0 0 None 0 0 None 1.87329E-05 0 1.79978E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1618 likely_benign 0.1541 benign -0.299 Destabilizing 0.822 D 0.473 neutral N 0.346214157 None None N
E/C 0.9211 likely_pathogenic 0.9254 pathogenic -0.059 Destabilizing 0.998 D 0.693 prob.neutral None None None None N
E/D 0.1195 likely_benign 0.096 benign -0.251 Destabilizing 0.002 N 0.169 neutral N 0.34444924 None None N
E/F 0.8215 likely_pathogenic 0.8297 pathogenic -0.248 Destabilizing 0.993 D 0.62 neutral None None None None N
E/G 0.1834 likely_benign 0.1521 benign -0.474 Destabilizing 0.822 D 0.483 neutral N 0.331881853 None None N
E/H 0.5753 likely_pathogenic 0.5628 ambiguous 0.082 Stabilizing 0.993 D 0.411 neutral None None None None N
E/I 0.5727 likely_pathogenic 0.548 ambiguous 0.121 Stabilizing 0.978 D 0.613 neutral None None None None N
E/K 0.1821 likely_benign 0.1733 benign 0.294 Stabilizing 0.822 D 0.467 neutral N 0.323734882 None None N
E/L 0.5446 ambiguous 0.5216 ambiguous 0.121 Stabilizing 0.978 D 0.593 neutral None None None None N
E/M 0.6025 likely_pathogenic 0.6013 pathogenic 0.15 Stabilizing 0.998 D 0.585 neutral None None None None N
E/N 0.3152 likely_benign 0.2724 benign 0.065 Stabilizing 0.754 D 0.433 neutral None None None None N
E/P 0.8095 likely_pathogenic 0.8274 pathogenic 0.001 Stabilizing 0.978 D 0.436 neutral None None None None N
E/Q 0.2052 likely_benign 0.1876 benign 0.092 Stabilizing 0.904 D 0.408 neutral N 0.335468128 None None N
E/R 0.3111 likely_benign 0.3117 benign 0.518 Stabilizing 0.978 D 0.409 neutral None None None None N
E/S 0.235 likely_benign 0.2056 benign -0.117 Destabilizing 0.86 D 0.45 neutral None None None None N
E/T 0.3057 likely_benign 0.2935 benign 0.024 Stabilizing 0.86 D 0.442 neutral None None None None N
E/V 0.3594 ambiguous 0.3415 ambiguous 0.001 Stabilizing 0.97 D 0.497 neutral N 0.38665426 None None N
E/W 0.9087 likely_pathogenic 0.9136 pathogenic -0.135 Destabilizing 0.998 D 0.722 prob.delet. None None None None N
E/Y 0.7056 likely_pathogenic 0.7147 pathogenic -0.017 Destabilizing 0.993 D 0.579 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.